Adalimumab-bwwd - NDC Database

7 records found
Page:1
78206-203 Jun 30, 2023
Adalimumab-bwwd-bwwd 40 mg/.8ml Subcutaneous Solution by Organon LLC
78206-204 Jun 30, 2023
Adalimumab-bwwd-bwwd 40 mg/.8ml Subcutaneous Solution by Organon LLC
78206-205 Jun 30, 2023
Adalimumab-bwwd-bwwd 40 mg/.8ml Subcutaneous Solution by Organon LLC
78206-206 Jun 30, 2023
Adalimumab-bwwd-bwwd 40 mg/.4ml Subcutaneous Solution by Organon LLC
78206-207 Jun 30, 2023
Adalimumab-bwwd-bwwd 40 mg/.4ml Subcutaneous Solution by Organon LLC
83457-186 Dec 12, 2025
Adalimumab-bwwd-bwwd 40 mg/.4ml Subcutaneous Solution by Cordavis Limited
83457-187 Dec 12, 2025
Adalimumab-bwwd-bwwd 40 mg/.4ml Subcutaneous Solution by Cordavis Limited
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.